Menu
Back to User profile » Dr Maxim Shevtsov
Papers published by Dr Maxim Shevtsov:
A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]
Klapproth AP, Shevtsov M, Stangl S, Li WB, Multhoff G
International Journal of Nanomedicine 2020, 15:6067-6068
Published Date: 13 August 2020
A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model
Klapproth AP, Shevtsov M, Stangl S, Li WB, Multhoff G
International Journal of Nanomedicine 2020, 15:4677-4689
Published Date: 30 June 2020
Improved osseointegration properties of hierarchical microtopographic/nanotopographic coatings fabricated on titanium implants
Zemtsova EG, Yudintceva NM, Morozov PE, Valiev RZ, Smirnov VM, Shevtsov MA
International Journal of Nanomedicine 2018, 13:2175-2188
Published Date: 11 April 2018
Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
Shevtsov M, Nikolaev B, Marchenko Y, Yakovleva L, Skvortsov N, Mazur A, Tolstoy P, Ryzhov V, Multhoff G
International Journal of Nanomedicine 2018, 13:1471-1482
Published Date: 12 March 2018
Experimental bladder regeneration using a poly-L-lactide/silk fibroin scaffold seeded with nanoparticle-labeled allogenic bone marrow stromal cells
Yudintceva NM, Nashchekina YA, Blinova MI, Orlova NV, Muraviov AN, Vinogradova TI, Sheykhov MG, Shapkova EY, Emeliannikov DV, Yablonskii PK, Samusenko IA, Mikhrina AL, Pakhomov AV, Shevtsov MA
International Journal of Nanomedicine 2016, 11:4521-4533
Published Date: 6 September 2016
Glu-Trp-ONa or its acylated analogue (R-Glu-Trp-ONa) administration enhances the wound healing in the model of chronic skin wounds in rabbits
Shevtsov MA, Smagina LV, Kudriavtceva TA, Petlenko SV, Voronkina IV
Drug Design, Development and Therapy 2015, 9:1717-1727
Published Date: 20 March 2015
Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children
Shevtsov MA, Kim AV, Samochernych KA, Romanova IV, Margulis BA, Guzhova IV, Yakovenko IV, Ischenko AM, Khachatryan WA
OncoTargets and Therapy 2014, 7:1071-1081
Published Date: 18 June 2014
Neurotherapeutic activity of the recombinant heat shock protein Hsp70 in a model of focal cerebral ischemia in rats
Shevtsov MA, Nikolaev BP, Yakovleva LY, Dobrodumov AV, Dayneko AS, Shmonin AA, Vlasov TD, Melnikova EV, Vilisov AD, Guzhova IV, Ischenko AM, Mikhrina AL, Galibin OV, Yakovenko IV, Margulis BA
Drug Design, Development and Therapy 2014, 8:639-650
Published Date: 28 May 2014
Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION–EGF) for targeting brain tumors
Shevtsov MA, Nikolaev BP, Yakovleva LY, Marchenko YY, Dobrodumov AV, Mikhrina AL, Martynova MG, Bystrova OA, Yakovenko IV, Ischenko AM
International Journal of Nanomedicine 2014, 9:273-287
Published Date: 3 January 2014